Dashboard
Manage Tickers

VXRTVaxart, Inc.

Nasdaq vaxart.com


$ 0.84 $ -0.02 (-2.75 %)    

Thursday, 18-Apr-2024 15:59:37 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 422.80 $ -2.43 (-0.57 %)
DIA $ 377.76 $ 0.39 (0.1 %)
SPY $ 499.54 $ -1.03 (-0.21 %)
TLT $ 88.82 $ -0.45 (-0.5 %)
GLD $ 220.32 $ 0.75 (0.34 %)
$ 0.8423
$ 0.84
$ 0.00 x 0
$ 0.00 x 0
$ 0.83 - $ 0.89
$ 0.53 - $ 1.59
883,544
na
146.44M
$ -0.92
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-14-2024 12-31-2023 10-K
2 11-02-2023 09-30-2023 10-Q
3 08-03-2023 06-30-2023 10-Q
4 05-04-2023 03-31-2023 10-Q
5 03-15-2023 12-31-2022 10-K
6 11-09-2022 09-30-2022 10-Q
7 08-08-2022 06-30-2022 10-Q
8 05-09-2022 03-31-2022 10-Q
9 02-24-2022 12-31-2021 10-K
10 11-04-2021 09-30-2021 10-Q
11 08-05-2021 06-30-2021 10-Q
12 05-06-2021 03-31-2021 10-Q
13 02-25-2021 12-31-2020 10-K
14 11-12-2020 09-30-2020 10-Q
15 08-06-2020 06-30-2020 10-Q
16 05-12-2020 03-31-2020 10-Q
17 03-19-2020 12-31-2019 10-K
18 11-12-2019 09-30-2019 10-Q
19 08-08-2019 06-30-2019 10-Q
20 05-09-2019 03-31-2019 10-Q
21 02-06-2019 12-31-2018 10-K
22 11-13-2018 09-30-2018 10-Q
23 08-10-2018 06-30-2018 10-Q
24 05-15-2018 03-31-2018 10-Q
25 02-06-2018 12-31-2017 10-Q
26 11-07-2017 09-30-2017 10-Q
27 09-01-2017 06-30-2017 10-K
28 05-08-2017 05-02-2017 10-Q
29 02-06-2017 12-31-2016 10-Q
30 11-08-2016 09-30-2016 10-Q
31 09-13-2016 06-30-2016 10-K
32 05-10-2016 03-31-2016 10-Q
33 02-08-2016 12-31-2015 10-Q
34 11-06-2015 09-30-2015 10-Q
35 09-11-2015 06-30-2015 10-K
36 05-08-2015 03-31-2015 10-Q
37 02-06-2015 12-31-2014 10-Q
38 11-07-2014 09-30-2014 10-Q
39 09-30-2014 06-30-2014 10-K
40 05-12-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

recap-vaxart-q4-earnings
Recap: Vaxart Q4 Earnings
03/14/2024 20:20:17

vaxart-q4-2023-gaap-eps-012-beats-014-estimate-sales-3245m-beat-1250m-estimate
Vaxart Q4 2023 GAAP EPS $(0.12) Beats $(0....
03/14/2024 20:10:32

Vaxart (NASDAQ:VXRT) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.14) by 14....

earnings-scheduled-for-march-14-2024
Earnings Scheduled For March 14, 2024
03/14/2024 09:52:13

Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.

vaxarts-earnings-a-preview
Vaxart's Earnings: A Preview
03/13/2024 19:01:18

vaxart-appoints-steven-lo-as-president-and-ceo
Vaxart Appoints Steven Lo As President And...
03/06/2024 13:11:08

Michael J. Finney, Ph.D. to Continue as Chairman of the Board of Directors

vaxart-announces-publication-in-vaccines-of-non-human-primate-preclinical-data-demonstrating-its-next-generation-vaccine-candidates-elicit-mucosal-and-systemic-immunogenicity-and-reduce-viral-shedding-after-sars-cov-2-challenge
Vaxart Announces Publication In Vaccines O...
02/05/2024 13:07:41

—  Data served as foundation for current vaccine candidate for planned Phase 2 research—  Vaxart vaccine candidates elicited st...

why-amd-shares-are-trading-lower-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why AMD Shares Are Trading Lower? Here Are...
01/31/2024 18:18:09

Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) shares declined 3.8% to $165.49 following fourth-quarter results. AMD rep...

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
01/31/2024 17:31:12

b-riley-securities-upgrades-vaxart-to-buy-announces-2-price-target
B. Riley Securities Upgrades Vaxart to Buy...
01/31/2024 14:48:27

B. Riley Securities analyst Mayank Mamtani upgrades Vaxart (NASDAQ:VXRT) from Neutral to Buy and announces $2 price target.

vaxart-receives-927m-barda-project-nextgen-award-to-prepare-for-phase-2b-clinical-study-evaluating-its-covid-19-oral-pill-vaccine-candidate
Vaxart Receives $9.27M BARDA Project NextG...
01/19/2024 13:30:55

- 10,000-subject Phase 2b study would evaluate Vaxart's next generation oral pill XBB COVID-19 vaccine against an approved ...

whats-going-on-with-vaxart-stock-today
What's Going On With Vaxart Stock Today?
01/17/2024 20:57:55

Vaxart shares are trading higher by around 8% Wednesday afternoon. The company recently secured a contract from the U.S. Govern...

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
01/16/2024 17:31:05

whats-going-on-with-vaxart-vxrt-stock
What's Going On With Vaxart (VXRT) Stock?
01/16/2024 15:59:41

Vaxart shares are trading higher by 17.8% Tuesday morning amid multiple news items. The company recently secured a contract fro...

update-on-jan-12-vaxart-announced-co-will-receive-an-award-to-support-clinical-trial-planning-activities-for-a-phase-2b-clinical-trial-that-would-compare-the-cos-xbb-vaccine-candidate-to-an-mrna-comparator-total-contract-value-of-927119300
UPDATE: On Jan. 12, Vaxart Announced Co Wi...
01/16/2024 15:36:31

On January 12, 2024, Vaxart, Inc. (the "Company") was awarded a contract (the "ASPR Contract") by the U.S. Gove...

vaxart-president-and-ceo-andrei-floroiu-resigns-chair-michael-finney-assumes-role-of-interim-ceo
Vaxart President And CEO Andrei Floroiu Re...
01/16/2024 14:29:37

Chief Executive Officer Andrei Floroiu Resigns Chair Michael J. Finney, Ph.D. to Serve as Interim Chief Executive Officer

vaxart-announces-10m-registered-direct-offering-with-ra-capital-management-for-sale-of-15384615-shares-at-065share
Vaxart Announces $10M Registered Direct Of...
01/16/2024 14:27:02

Gross proceeds are approximately $10.0 million, before deducting expenses payable by Vaxart. Vaxart intends to use the net proc...

vaxart-on-jan-12-awarded-aspr-contract-by-us-government
Vaxart On Jan. 12, Awarded ASPR Contract B...
01/16/2024 14:24:08

-SEC 8K Filing

vaxart-announces-last-subject-dosed-in-phase-1-trial-of-its-norovirus-vaccine-candidate-in-lactating-mothers
Vaxart Announces Last Subject Dosed In Pha...
12/21/2023 13:04:18

On track to report topline data by the end of 2024 SOUTH SAN FRANCISCO, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) -- Vaxart, Inc. ...

vaxart-q3-eps-011-beats-018-estimate-sales-210m-beat-10000k-estimate
Vaxart Q3 EPS $(0.11) Beats $(0.18) Estima...
11/02/2023 20:24:05

Vaxart (NASDAQ:VXRT) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.18) by 38....

vaxart-doses-first-subject-i-phase-1-trial-of-its-norovirus-vaccine-candidate-in-lactating-mothers
Vaxart Doses First Subject I Phase 1 Trial...
11/02/2023 12:12:50

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

04/22/2024 Dick's Sporting Goods, Inc. (DKS)
04/22/2024 Innodata Inc. (INOD)
04/22/2024 Fox Factory Holding Corp. (FOXF)
04/23/2024 Lantronix, Inc. (LTRX)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)